Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @crypto_biotech

$GLSI

BULLISH2026-07-16

Price around the call

↑ 2026-07-16

By horizonMaturing · ~14 trading days to go

✗ -13.6%

✗ -19.9%

21d

…

Original post

BioPharm_the_Magnificent · 2026-07-16

$GLSI https://t.co/4lvNn6U2k8 1. Major enrollment acceleration following the July 16 EMA approval 2. Strong supportive efficacy signals now showing in a larger patient population 3. Manufacturing & supply chain fully de-risked 4. Large unmet need + FDA Fast Track + clear path to a broader label 5. Attractive valuation with significant analyst upside A partnership or CVR looks increasingly realistic. With the ability to now include both HLA populations, the company is pursuing a meaningfully broader label than the original HLA-A*02-only approach. This substantially expands the commercial opportunity. Probably the most overlooked biotech on the planet right now. No more lending your shares out. Let’s go. 🔥

View on X ↗